ANTI-MALARIAL DRUGS MARKET ANALYSIS

Anti-malarial Drugs Market, By Drug Class (Aminoquinolines, Quinoline-methanol (4-quinolinemethanols), Cinchona Alkaloids, Biguanides, Sulfonamides and Sulfones, and Others), By Route of Administration (Oral and Injectable), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)

Published In : Jun 2023
Code : CMI3726
Pages :162
Formats :
Excel and PDF
Industry : Pharmaceutical

Anti-Malarial Drugs MarketSize and Trends

The global anti-malarial drugs market is estimated to be valued at US$ 989.7 million in 2023 and is expected to exhibit a CAGR of 4.5% during the forecast period (2023-2030).

Figure 1. Global Anti-malarial Drugs Market Share (%), by Drug Class, 2023

Global Anti-malarial Drugs Market Trends:

Rising demand of research and development, increasing need to treat malaria patients and surging demand of combination therapy

Rising demand of malarial treatment, increasing need to treat malaria patients and surging demand of combination therapy, the anti-malarial drugs market is expected to experience considerable expansion in the African region. For instance, in July 2022, MMV, a product development partnership in the field of antimalarial drug research and development, announced the start of ARCTIC (Assessing Radical Cure Treatment In routine Care), a feasibility study of a new Plasmodium vivax malaria treatment protocol. This study is using single-dose tafenoquine in the Asia Pacific region and provide evidence to the Thai Ministry of Public Health on the potential role for these tools in supporting the country’s 2024 malaria elimination goal.